C J Yu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

C J Yu

Showing results (151-160 of 152) with videos related to

Pageof 16

Sort By:

You have reached the last page of results.This site can display upto 152 results.

ESMO Open|February 14, 2022

First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patientsK J O'Byrne, K H Lee, S-W Kim, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2021

Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancerS Sugawara, J-S Lee, J-H Kang, et al.

Pageof 16

Search research articles

Showing results (151-160 of 152) with videos related to

Sort By:

Pageof 16

You have reached the last page of results.This site can display upto 152 results.

ESMO Open|February 14, 2022

First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patientsK J O'Byrne, K H Lee, S-W Kim, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2021

Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancerS Sugawara, J-S Lee, J-H Kang, et al.

Pageof 16